Actively Recruiting

Age: 0 - 3Years
All Genders
NCT06184503

Analysis of Velmanase Alfa (Lamzede®)'s Effects in the Body of Children With Alpha-Mannosidosis Under the Age 3

Led by Chiesi Farmaceutici S.p.A. · Updated on 2025-05-16

5

Participants Needed

2

Research Sites

236 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this observational study is to learn the effects of the drug velmanase alfa (Lamzede®) in the bodies of children under the age of 3 with Alpha-Mannosidosis. The main questions it aims to answer are: * study the effect of velmanase alfa on a marker of the disease called GlcNAc(Man)2 after one year of therapy * explore how the child's body reacts to velmanase alfa during the therapy The parents or legal guardians of participants will be asked to provide the results of analyses performed in the routine clinical setting related to the participant's general health and the administration of velmanase alfa. Additional data will be extracted from other observational sponsored studies/registries, compassionate use programs, investigator-initiated studies (IIS), and published case reports (presented in the literature) if existing.

CONDITIONS

Official Title

Analysis of Velmanase Alfa (Lamzede®)'s Effects in the Body of Children With Alpha-Mannosidosis Under the Age 3

Who Can Participate

Age: 0 - 3Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Legal guardian provides informed consent
  • Confirmed diagnosis of alpha mannosidosis
  • Started velmanase alfa treatment between birth and before 3 years old
  • Has disease marker GlcNAc(Man)2 measured before treatment (within 6 months) and after at least 6 weeks of treatment
  • Received velmanase alfa at 1 mg/kg via weekly intravenous infusions
Not Eligible

You will not qualify if you...

  • Prior hematopoietic stem cell transplantation (HSCT)
  • Use of other investigational treatments for alpha mannosidosis (supportive treatments allowed)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Nicklaus Children's Hospital

Miami, Florida, United States, 33155

Actively Recruiting

2

Greenwood Genetic Center

Greenwood, South Carolina, United States, 29605

Actively Recruiting

Loading map...

Research Team

C

Chiesi Clinical trials

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Analysis of Velmanase Alfa (Lamzede®)'s Effects in the Body of Children With Alpha-Mannosidosis Under the Age 3 | DecenTrialz